Wilson's disease

Italian Journal of Gastroenterology and Hepatology

Volumn 31, Issue 5, 1999, Pages 416-425

  Ferenci, P ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chronic liver diseases; Neurodegenerative disorders; Wilson's disease

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CERULOPLASMIN; CHELATING AGENT; COPPER; PENICILLAMINE; PYRIDOXINE; TETRATHIOMOLYBDATE AMMONIUM; TRIENTINE; ZINC;

ACUTE HEPATITIS; AUTOSOMAL RECESSIVE DISORDER; CHROMOSOME 13; CHRONIC HEPATITIS; CLINICAL FEATURE; COPPER METABOLISM; GENE MUTATION; GOODPASTURE SYNDROME; HEMOLYTIC ANEMIA; HUMAN; IMMUNE COMPLEX NEPHRITIS; LEUKOPENIA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER LEVEL; LIVER TRANSPLANTATION; MOUTH ULCER; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; OPTIC NERVE DISEASE; PATHOGENESIS; PEMPHIGUS; POINT MUTATION; PYRIDOXINE DEFICIENCY; REVIEW; SKIN DEFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; WILSON DISEASE;

EID: 0032768642     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Reilly M, Daly L, Hutchinson M. An epidemiological study of Wilson's disease in the Republic of Ireland. J Neurol Neurosurg Psychiatry 1993;56:298-300.
2. Bachmann H, Lössner J, Kühn HJ, Siegemund R. Occurrence, genetics and epidemiology of Wilson's disease in East Germany. In: Czlonkowska A, van der Hamer CJA, editors. Proc. 5th. Intern. Symposium on Wilson's disease. Technical Univ. Delft; 1991. p. 121-8.
3. Figus A, Angius A, Loudianos O, Bertini C, Dessi V, Loi A, et al. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations. Am J Hum Genet 1995;57:1318-24.
4. Sokol RJ, Devereaux MW, O'Brien K, Khandawala RA, Loehr JP. Abnormal hepatic mitochondrial respiration and cytochrome oxidase activity in rats with long-term copper overload. Gastroenterology 1993;105:178-87.
5. Sokol RJ, Twedt D, McKim JM Jr, Devereaux MW, Karrer FM, Kam I, et al. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology 1994;107:1788-98.
6. Leung TK, Lim L, Lai JC. Differential effects of metal ions on type A and type B monoamine oxidase activities in rat brain and liver mitochondria. Metab Brain Dis 1992;7:139-46.
7. Petrukhin KE, Lutsenko S, Chernov I, Ross BM, Kaplan JH, Gilliam TC. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet 1994;3:1647-56.
8. Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Gen 1993;5:344-50.
9. Thomas GJ, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 1995;9:210-7.
10. Czlonkowska A, Rodo M, Gajda J, Ploos van Amstel HK, Juyn J, Houwen RH. Very high frequency of the His1069Gln mutation in Polish Wilson disease patients. J Neurol 1997;244:591-2.
11. Waldenstrom E, Lagerkvist A, Dahlman T, Westermark K, Landegren U. Efficient detection of mutations in Wilson disease by manifold sequencing. Genomics 1996;37:303-9.
12. Maier-Dobersberger T, Ferenci P, Polli C, Balac P, Dienes HP, Kaserer K, et al. The His1069Gln mutation in Wilson's disease: detection by a rapid PCR-test, clinical course, and liver biopsy findings. Ann Intern Med 1997;127:21-6.
13. Loudianos G, Dessi V, Lovicu M, Angius A, Nurchi A, Sturniolo GC, et al. Further delineation of the molecular pathology of Wilson's disease in the Mediterranean population. Hum Mutat 1998;12:89-94.
14. Chuang LM, Wu HP, Jang MH, Wang TR, Sue WC, Lin BJ, et al. High frequency of two mutations in codon 778 in exon 8 of the ATP7B gene in Taiwanese families with Wilson disease. J Med Genet 1996;33:521-3.
15. Houwen RH, Juyn J, Hoogenraad TU, Ploos van Amstel JK, Berger R. H714Q mutation in Wilson's disease is associated with late, neurological presentation. J Med Genet 1995;32:480-2.
16. Thomas GR, Jensson O, Gudmundsson G, Thorsteinsson L, Cox DW. Wilson disease in Iceland: a clinical and genetic study. Am J Hum Genet 1995;56:1140-6.
17. Butler P, McIntyre N, Mistry PK. Molecular diagnosis of Wilson's disease in a Greek cohort of patients. Hepatology 1998;28:529A
18. Vulpe CD, Packman S. Cellular copper transport. Annu Rev Nutr 1995;15:293-322.
19. ++ and ATP. J Biol Chem 1996;271:1972-8.
20. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD. Aceruloplasminaemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 1995;92:2539-43.
21. Harris ED. The iron-copper connection: the link to ceruloplasmin grows stronger. Nutr Rev 1995;53:170-3.
22. Dijkstra M, Vonk RJ, Kuipers F. How does copper get into bile? New insights into the mechanism(s) of hepatobiliary copper transport. J Hepatol 1996;24 (Suppl. 1):109-20.
23. Payne AS, Kelly EJ, Gitlin JD. Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation. PNAS USA 1998;95:10854-9.
24. Lutsenko S, Cooper MJ. Localization of the Wilson's disease protein product to mitochondria. Proc Natl Acad Sci USA 1998;95:6004-9.
25. Terada K, Nakako T, Yang XL, Iida M, Aiba N, Minamiya Y, et al. Restoration of holoceruloplasmin synthesis in LEG rat after infusion of recombinant adenovirus bearing WND cDNA. J Biol Chem 1998;273:1815-20.
26. Me Cullough AJ, Fleming CR, Thistle JL, Baldus WP, Ludwig J, McCall JT, et al. Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology 1983;84:161-7.
27. Berman DH, Leventhal RI, Gavaler JS, Cadoff EM, Van Thiel DH. Clinical differentiation of fulminant wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991;100:1129-34.
28. Scott J, Gollan JL, Samourian S, Sherlock S. Wilson's disease, presenting as chronic active hepatitis. Gastroenterology 1978;74:645-51.
29. Scheinberg IH, Sternlieb I, editors. Wilson's disease. Vol 23. Major problems in internal medicine. Philadelphia: Saunders; 1984.
30. Oder W, Grimm G, Kollegger H, Ferenci P, Schneider B, Deecke L. Neurological and neuropsychiatrie spectrum of Wilson's disease. A prospective study in 45 cases. J Neurol 1991;238:281-7.
31. Sternlieb I. Perspectives on Wilson's disease. Hepatology 1990;12:1234-9.
32. Demirkiran M, Jankovic J, Lewis RA, Cox DW. Neurologic presentation of Wilson disease without Kayser-Fleischer rings. Neurology 1996;46:1040-3.
33. van Wassenaer-van Hall HN, van den Heuvel AG, Algra A, Hoogenraad TU, Mali WP. Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology 1996;198:531-6.
34. Grimm G, Madl Ch, Katzenschlager R, Oder W, Ferenci P, Gangl A. Detailed evaluation of brain dysfunction in patients with Wilson's disease. Electroencephalogr Clin Neurophysiol 1992;82:119-24.
35. Grimm G, Oder W, Prayer L, Ferenci P, Madl Ch. Prospective follow-up study in Wilson's disease. Lancet 1990;336:963-4.
36. Steindl P, Ferenci P, Dienes HP, Grimm G, Pabinger I, Madl Ch, et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 1997;113:212-8.
37. Cauza E, Maier-Dobersberger T, Ferenci P. Plasma ceruloplasmin as screening test for Wilson's disease. J Hepatol 1997;27:358-62.
38. Da Costa CM, Baldwin D, Portmann B, Lolin Y, Mowat AP, Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology 1992;15:609-15.
39. McDonald JA, Snitch P, Painter D, Hensle W, Gallagher ND, McCaughan GW. Striking variability of hepatic copper levels in fulminant hepatic failure. J Gastroenterol Hepatol 1992;7:396-8.
40. Ludwig J, Moyer TP, Rakela J. The liver biopsy diagnosis of Wilson's disease. Am J Clin Pathol 1994;102:443-6.
41. Cox DW. Molecular advances in Wilson disease. In: Progress in Liver Disease, Vol. X, 1996, Chapter 10; p. 245-63.
42. Maier-Dobersberger Th, Rack S, Granditsch G, Korninger L, Steindl P, Mannhalter Ch, et al. Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis. Gastroenterology 1995;109:2015-8.
43. Vidaud D, Assouline B, Lecoz P, Cadranel JF, Chappuis P. Misdiagnosis revealed by genetic linkage analysis in a family with Wilson disease. Neurology 1996;46:1485-6.
44. Walshe JM, Yealland M. Chelation treatment of neurological Wilson's disease. Q J Med 1993;86:197-204.
45. Scheinberg IH, Jaffe ME, Sternlieb I. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. N Engl J Med 1987;317:209-13.
46. Brewer GJ, Johnson V, Dick RD, Kluin KJ, Fink JK, Brunberg JA. Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 1996;53:1017-25.
47. Yuzbasiyan-Gurkan V, Grider A, Nostrant T, Cousins RJ, Brewer GJ. Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction. J Lab Clin Med 1992;120:380-6.
48. Lee DY, Brewer GJ, Wang Y. Treatment of Wilson's disease with zinc. VII. Protection of the liver from copper toxicity by zinc-induced metallothionein in a rat model. J Lab Clin Med 1989;114:639-45.
49. Ferenci P. Zinc treatment of Wilson's disease. In: Kruse-Jarres JD, Schölmerich J, editors. Zinc and diseases of the digestive tract. Lancaster: Kluwer Academic publishers; 1997. p. 117-24.
50. Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. The treatment of Wilson's disease with zinc. XV: Long-term follow-up studies. J Lab Clin Med 1999 (in press).
51. Brewer GJ, Yuzbasiyan Gurkan V, Lee DY, Appelman H. Treatment of Wilson's disease with zinc. VI. Initial treatment studies. J Lab Clin Med 1989;114:633-8.
52. Czlonkowska A, Gajda J, Rodo M. Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate. J Neurol 1996;243:269-73.
53. Schilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation for Wilson's disease: indications and outcome. Hepatology 1994;19:583-7.
54. Bellary S, Hassanein T, Van Thiel DH. Liver transplantation for Wilson's disease. J Hepatol 1995;23:373-81.
55. Guarino M, Stracciari A, D'Alessandro R, Pazzaglia P. No neurological improvement after liver transplantation for Wilson's disease. Acta Neurol Scand 1995;92:405-8.